Imfinzi plus chemotherapy approved in the US as the first immunotherapy regimen for patients with advanced biliary tract cancer Read more
FDA approves the first treatment option for generalized pustular psoriasis flares in adults Read more
FDA approves the first treatment option for generalized pustular psoriasis flares in adults Read more
Cambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina Read more
ProofPilot Announces Partnership with Human API to Advance Patient Screening and Clinical Monitoring in Research Read more
Maze Therapeutics Announces FDA Orphan Drug Designation Granted to MZE001 for the Treatment of Pompe Disease Read more
Novavax Nuvaxovid COVID-19 Vaccine Recommended by CHMP for Expanded Conditional Marketing Authorization in the European Union as a Booster for Adults Aged 18 and Older Read more
Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders Read more